Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer

Assessing the extent of phosphoinositol 3-kinase (PI3K) pathway activity in cancer is vital to predicting sensitivity to PI3K-targeting drugs but the best biomarker of PI3K pathway activity in archival tumor specimens is unclear. Here PI3K pathway activation was assessed, in clinical tissue from 1,0...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Cancer Res
Auteurs principaux: Martin, Neil E, Gerke, Travis, Sinnott, Jennifer A, Stack, Edward C, Andrén, Ove, Andersson, Swen-Olof, Johansson, Jan-Erik, Fiorentino, Michelangelo, Finn, Stephen, Fedele, Giuseppe, Stampfer, Meir, Kantoff, Philip W, Mucci, Lorelei A, Loda, Massimo
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4618038/
https://ncbi.nlm.nih.gov/pubmed/26124442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-14-0569
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires